P
ProHub
English 简体中文 繁體中文
Easy Product Launch

Stick A Needle In My Eye

#Healthcare
ProHub Comment

This case tests the candidate's ability to balance quantitative pricing analysis with qualitative stakeholder management. The key insight is recognizing that numerical market attractiveness can be undermined by end-user resistance, particularly from nursing staff who are critical to product adoption. Strong candidates identify that the 65% negative feedback from nurses should override the positive sentiment from other stakeholders.

Estimated Time 16 minutes
Difficulty Easy
Source Wharton
10 / 100
VaxCo, a leading vaccine manufacturer, has innovated a hybrid method of vaccine delivery, where instead of using a vial for storing the vaccine and a syringe for injecting it, a vial with a needle would be used to both store and inject the vaccine by a nurse. VaxCo has hired us to understand whether a market exists for such a product, and how to price it.

Clarifying Information

  1. VaxCo has spent $5M in R&D for this hybrid method. The method is ready, and is patented
  2. VaxCo is yet to obtain regulatory approvals from medical agencies for this hybrid method
  3. Currently, VaxCo only manufactures vaccines and the vial it goes in, and has no syringe manufacturing experience, but with suitable investments, has the capability to manufacture the needled vials in-house
  4. Typically, vaccines are administered to the patients via syringes by nursing staff. Doctors take up that responsibility in rare instances
Mock Interview
Interviewer

VaxCo, a leading vaccine manufacturer, has innovated a hybrid method of vaccine delivery, where instead of using a vial for storing the vaccine and a syringe for injecting it, a vial with a needle would be used to both store and inject the vaccine by a nurse. VaxCo has hired us to understand whether a market exists for such a product, and how to price it.

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

VaxCo seeks to launch a hybrid vaccine vial-needle combination to streamline delivery. While financially attractive and supported by doctors, hospital admin, and patients, the nursing staff overwhelmingly opposes it due to retraining burden and complications with partial dose delivery (30% of all doses). The recommendation is to pause launch pending stakeholder concerns resolution.

Key Insights:

  1. End-user resistance from the primary stakeholder (nursing staff) can be a deal-breaker regardless of other stakeholder support or profit potential
  2. Pricing strategy should consider both cost-based ($17 keeping margin same) and value-based ($20 keeping customer price same) approaches, with tradeoffs between competitiveness and customer incentive to switch
  3. Operational constraints like partial dose delivery challenges represent real barriers that may require product redesign before successful market entry
  4. The $5M sunk cost in R&D should not drive a go/no-go decision; focus should remain on market viability and stakeholder acceptance